SHALBYShalby Ltd.

₹254.2+0.85%

Market Cap

₹2,722.39 Cr

Stock P/E

-5317.51

ROCE

7.07%

ROE

0.19%

Book Value

₹92.51

Financials

YoY Net Sales

EPS Growth

Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Institution

Others

From Last Concall

POSITIVES

•
First-time quarterly revenue crossing INR 300 crores, signaling scale and momentum.
•
Strong balance sheet with net cash and low gearing, plus standalone ROCE of 12.5% in the quarter.

NEGATIVES

•
Occupancy decline year-on-year, with occupied beds at 639 this quarter (down from 669), and overall occupancy ~45%.
•
Shalby Sanar international occupancy remains weak at ~22% due to geopolitical disruptions, impacting top line.

Peers Summary

Sector Leader

Shalby Ltd. displays solid growth and reasonable profitability metrics compared to its peers in the Hospital & Healthcare Services industry. While it has a moderate valuation, some peers present more attractive investment opportunities due to their lower PE ratios or stronger financial metrics.

Key Points

• Shalby Ltd. shows a revenue growth rate of 16.01% YoY, indicating strong performance.
• With a PE ratio of 25.30, Shalby is reasonably valued compared to peers, but several other companies offer better value.
• Debt levels are manageable with a debt-to-equity ratio of 0.3141, suggesting lower financial risk.

Top Performers

Narayana Hrudayalaya Ltd.

Highest ROE of 24.27% and solid earnings growth.

Global Health Ltd.

Strong revenue growth at 21.56% YoY and good profitability metrics.

Explore

Watchlists

Command Palette